1 янв 2014 г. - Pembrolizumab
Описание:
Pembrolizumab is approved for advanced melanoma treatment by the FDA. This monoclonal antibody blocks a protein called PD1's activity on immune cells, which increases the strength of the immune response to cancer.
Добавлено на ленту времени:
Cancer
Дата: